This blog is an extension of our poster presented at ISPOR 2025, titled Real-world temporal and indication-specific variation in drivers of GLP-1 RA discontinuation
The CMS said it will launch a short-term GLP-1 payment model in July 2026 that it says "will serve as a short-term bridge to the model," allowing beneficiaries to access lowest costs for these drugs before the model fully launches
Indeed euphoric with the inclusive quality
A part of Watch Medier Medical Writer responsible for Clinical Disclosure Clinical Supply Manager Pharmacokineticist, PK/PD Modelling & Simulation Global Clinical Lead, Clinical Development, Migraine & Pain Senior Safety Manager Director, Drug Safety Operations You need to be a subscriber to read the rest of the article
An 8-week randomized double-blind trial comparing GHK-Cu in nano-lipid carrier against Matrixyl 3000 showed 55.8% reduction in wrinkle volume versus control and 31.6% reduction versus the active comparator
Bioma probiotics can help with gut microbiome rebalancing and even help clear harmful bacteria